Terns Pharmaceuticals, Inc. (TERN)
SEC fundamentals · as filed in 10-K FY2025, period ended Dec 31, 2025 · updated Oct 7, 2026
as filed in 10-K FY2025, period ended Dec 31, 2025 · View filings on EDGAR ↗
In its 10-K for the period ended Dec 31, 2025, Terns Pharmaceuticals, Inc. reported net income of -$96.2M and total assets of $1.03B. Every figure below is taken directly from Terns Pharmaceuticals, Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | — | -$96.2M |
| FY2024 | — | -$88.9M |
| FY2023 | — | -$90.2M |
| FY2022 | $0 | -$60.3M |
| FY2021 | $1.0M | -$50.2M |
| FY2020 | $0 | -$40.1M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | May 5, 2026 | on EDGAR ↗ |
| 8-K | Apr 27, 2026 | on EDGAR ↗ |
| 10-K/A | Apr 27, 2026 | on EDGAR ↗ |
| 10-K | Mar 30, 2026 | on EDGAR ↗ |
| 8-K | Mar 25, 2026 | on EDGAR ↗ |
| 8-K | Jan 22, 2026 | on EDGAR ↗ |
| 8-K | Jan 9, 2026 | on EDGAR ↗ |
| 8-K | Dec 11, 2025 | on EDGAR ↗ |
| 8-K | Dec 8, 2025 | on EDGAR ↗ |
| 8-K | Nov 10, 2025 | on EDGAR ↗ |
Balance Sheet
as of Dec 31, 2025 · 10-K
Income Statement
10-K (annual) · period ended Dec 31, 2025
Per Share & Cash Flow
10-K (annual) · period ended Dec 31, 2025
| EPS (diluted) | $-1.03 | Earnings | source ↗ |
| EPS (basic) | $-1.03 | Earnings | source ↗ |
| Shares Outstanding | 115.4M | Entity | source ↗ |
| Cash from Operations | -$82.2M | Net | source ↗ |
| Cash from Financing | $743.5M | Net | source ↗ |
| Cash from Investing | -$298.0M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
No open-market Form 4 transactions filed in the last 180 days.
Restatement history
Point-in-timeNo material restatements detected across 134 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches TERN’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/TERN
MCP tool:
get_sec_fundamentals ticker=TERN - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/TERN/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=TERN as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/TERN/history
MCP tool:
get_fundamentals_history ticker=TERN - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/TERN
MCP tool:
get_financial_health ticker=TERN
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.